Endogastric Solutions Logo
  • Home
  • Patients
    • Take me to Gerdhelp.com
  • Providers
    • TIF 2.0®
      • EsophyX® Device
    • cTIF™
    • Support
      • Training and Education
      • Reimbursement
      • Community Outreach
      • Regulatory Labeling
      • Data & Bibliography
    • Referring Physicians
    • Events
  • About Us
    • Leadership
      • Executive Team
      • Medical Advisory Board
      • Board of Directors
    • Careers
    • Investors
    • News
      • Press Releases
      • Videos
  • Contact
Endogastric Solutions Logo
  • Patients
  • Providers
  • About Us
  • Contact

EndoGastric Solutions Announces Publication of Landmark Data in Gastroenterology Demonstrating Superiority of Transoral Incisionless Fundoplication For Treatment of Troublesome Regurgitation

Jan 21, 2015

Significantly More TIF/Placebo Patients Experienced Elimination of Troublesome Regurgitation as Compared to Sham/PPI Patients SAN MATEO, Calif.–EndoGastric Solutions (EGS) announces that Gastroenterology, the official journal of the American Gastroenterological...

EndoGastric Solutions Advances EsophyX® Platform with the Launch of EsophyX®2 HD Device

Dec 10, 2014

Now physicians can utilize the latest-generation high definition (HD) endoscopes when performing Transoral Incisionless Fundoplication (TIF®) procedures to treat the underlying, anatomical causes of GERD SAN MATEO, Calif. (Dec. 10, 2014)–EndoGastric Solutions® (EGS),...

Incisionless Procedure Improves Long-Term GERD Symptoms, 70% of Patients Are Able to Stop Taking Proton Pump Inhibitor Medications for Two Years

Oct 29, 2014

EndoGastric Solutions Reports Two-Year Durability Data from TIF Registry for GERD Patients Choosing Transoral Incisionless Fundoplication (TIF®) SAN MATEO, Calif. (Oct. 29, 2014)–EndoGastric Solutions® (EGS) announced publication of US registry data showing that...

EndoGastric Solutions announces TIF® Procedure Significantly More Effective than PPI in Eliminating Troublesome Regurgitation in Patients with Long-Term GERD

Oct 20, 2014

Six-month results of the first-ever sham and placebo-controlled study of a transoral endoscopic procedure for GERD presented at American College of Gastroenterology (ACG) 2014 Annual Scientific Meeting SAN MATEO, Calif. (Oct. 20, 2014)–EndoGastric Solutions (EGS)...
« Older Entries
Next Entries »
EndoGastric Solutions logo
  • Patients
  • Providers
  • About Us
  • Contact Us
  • GERDHelp for Patients
  • References
  • Privacy
  • Terms of Use
  • Social Media Policy
  • Corporate Compliance
  • Facebook
  • X
  • Instagram
  • RSS
© 2023 EndoGastric Solutions, Inc. All rights reserved.
EndoGastric, EsophyX, SerosaFuse, TIF, TIF 2.0 and cTIF names and logos, are registered trademarks of EndoGastric Solutions. All other product names and logos are trademarks or registered trademarks of their respective holders.